Metolazone and its role in edema management

Congestive Heart Failure

Volumn 9, Issue 2, 2003, Pages 100-105

  Sica, Domenic A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; FUROSEMIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE;

ALKALOSIS; ASCITES; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; DIURESIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; EDEMA; ELECTROLYTE DISTURBANCE; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART VENTRICLE OVERLOAD; HEART VOLUME; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; KIDNEY CLEARANCE; LIVER CIRRHOSIS; LUNG DYSPLASIA; NEPHROTIC SYNDROME; PEDIATRICS; REVIEW; TABLET; WEIGHT REDUCTION;

EID: 0037363967     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2003.01907.x     Document Type: Review

References (60)

1. Epstein M, Lepp BA, Hoffman DS, et al. Potentiation of furosemide by metolazone in refractorv edema. Curr Ther. 1977;21:656-667.
2. Garin EH, Richard GA. Edema resistant to furosemide therapy in nephrotic syndrome: treatment with furosemide and metolazone. Int J Pediatr Nephrol. 1981;2:181-184.
3. Garin EH. A comparison of combinations of diuretics in nephrotic edema. Am J Dis Child. 1987;141:769-771.
4. Allen JM, Hind CRK, McMichael HB. Synergistic action of metolazone with 'loop' diuretics [letter]. BMJ. 1981;282: 1873.
5. Arnold WC. Efficacy of metolazone and furosemide in children with furosemide-resistant edema. Pediatrics. 1984;74: 872-875.
6. Asscher AW. Treatment of frusemide resistant oedema with metolazone. Clin Trials J. 1974;11:134-139.
7. Black WD, Shiner PT, Roman J. Severe electrolyte disturbances associated with metolazone and furosemide. South Med J. 1978;71:380-382.
8. Brater DC, Pressley RH, Anderson SA. Mechanisms of the synergistic combination of metolazone and bumetanide. J Pharmacol Exp Ther. 1985;233:70-74.
9. Craswell PW, Ezzat E, Kopstein J, et al. Use of metolazone, a new diuretic, in patients with renal disease. Nephrology. 1973; 12:63-73.
10. Gage JS, Mancini DM, Gumbardo W, et al. Efficacy of combined diuretic therapy with metolazone and furosemide in patients with refractory congestive heart failure. Cardiovasc Rev Rep. 1986;7:814-817.
11. Ghose RR, Gupta SK. Synergistic action of metolazone with 'loop' diuretics. BMJ. 1981;282:1432-1433.
12. Grosskopf I, Rabinovitz M, Rosenfeld JB. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Isr J Med Sci. 1986;22:787-790.
13. Gunstone RF, Wing AJ, Shani HGP, et al. Clinical experience with metolazone in fifty-two African patients: synergy with furosemide. Postgrad Med J. 1971;47:789-793.
14. Kshinsagar NA, Gupta KC, Paul T, et al. Effect of metolazone addition on furosemide-resistant cases of edema. J Assoc Phys India. 1978;26:915-923.
15. Hropot M, Sorgel F, Mutschler E. Pharmacodynamics and pharmacokinetics of furosemide-combinations with potassium-retaining and thiazide-like diuretics: clearance and micropuncture studies. Naunyn Schmiedebergs Arch Pharmacol. 1986;333:457-461.
16. + reabsorption by lithium clearance in nephrotic patients. In: Puschett JB, ed. Diuretics. III: Chemistry, Pharmacology and Clinical Applications. Amsterdam, The Netherlands: Elsevier; 1990:38-40.
17. Marone C, Muggli CMF, Lahn W, et al. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur J Clin Invest. 1985;15:253-257.
18. Oster JR, Epstein M, Smoller S. Combined therapy with thiazide-type and 'loop' diuretic agents for resistant sodium retention. Ann Intern Med. 1983;99:405-406.
19. Ram CVS, Reichgott MJ. Treatment of loop-diuretic resistant edema by the addition of metolazone. Curr Ther. 1977;22: 686-691.
20. Kiyingi A, Field MJ, Pawsey CC, et al. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet. 1990;335:29-31.
21. Segar JL, Robillard JE, Johnson KJ, et al. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia. J Pediatr. 1992;120:966-973.
22. Cachero SD, Lofland G, Spriungate JE, et al. Combination of metolazone and furosemide in the treatment of edema in the first month of life. Child Nephrol Urol. 1990;10:161-163.
23. Garin EH, Richard GA. Metolazone and furosemide for edema. Pediatrics. 1986;77:130-131.
24. Aravot DJ, Banner NR, Musumeci F, et al. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure. Lancet. 1989;1(8640):727-728.
25. Farthing D, Sica DA, Fakhry I, et al. A novel HPLC method using solid phase on-line elution for determination of metolazone in plasma and whole blood. J Chromatogr B Biomed Appl. 1994;653:171-176.
26. Knauf H, Mutschler E. Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy. Eur J Clin Pharmacol. 1991;44(suppl 1):S63-S68.
27. Fliser D, Schroter M, Neubeck M, et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int. 1994;46: 482-488.
28. Sica DA, Gehr TWB. Diuretic use in end-stage renal disease. Semin Dial. 1995;8:305-310.
29. Channer KS, McLean KA, Lawson-Matthew P, et al. Combination diuretic treatment in severe heart failure: a randomized clinical trial. Br Heart J. 1994;71:146-150.
30. Sica DA, Gehr TWB. Diuretic combinations in refractory oedema state. Clin Pharmacokinet. 1996;30:229-249.
31. Dormans TP, Gerlag PG, Russel FG, et al. Combination diuretic therapy in severe congestive heart failure. Drugs. 1998; 55:165-172.
32. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;144:31-38.
33. Broadley AJ, Marshall AJ. Self administration of metolazone reduces readmissions with decompensated congestive heart failure. Heart. 1999;82(3):397-398.
34. Ramahi TM, Longo MD, Rohlfs K, et al. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clin Cardiol. 2000;23:909-914.
35. Belair EJ, Cohen AL, Yelnosky J. Renal excretion of metolazone, a new diuretic. Br J Pharmacol. 1972;45:476-479.
36. Sica DA, Brater DC, Centor R, et al. Metolazone-probenecid interaction in man [abstract]. Clin Res. 1987;35:381A.
37. Tilstone WJ, Dargie H, Dargie EN, et al. Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clin Pharmacol Ther. 1974;16:322-329.
38. Kempson SA, Kowalski JC, Puschett J. Direct effect of metolazone on sodium-dependent transport across the renal brush border membrane. J Lab Clin Med. 1983;101:308-316.
39. Steinmuller SR, Puschett JB. Effects of metolazone in man: comparison with chlorothiazide. Kidney Int. 1972;1:169-181.
40. Fernandez PC, Puschett JB. Proximal tubular actions of metolazone and chlorothiazide. Am J Physiol. 1973;225: 954-961.
41. Suki WN, Dawoud F, Eknoyan G, et al. Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther. 1972; 180:6-12.
42. 14C-metolazone, in dogs. J Pharm Sci. 1973;62:931-936.
43. 14C-Zaroxylyn, a new diuretic, to blood fractions and the pattern of metabolites in man and other species [abstract]. Proc Can Fed Biol Sci. 1970;13:155.
44. 14C-counting techniques [abstract]. Fed Proc. 1970;29:276.
45. Dargie HJ, Allison MEM, Kennedy AC, et al. Efficacy of metolazone in patients with renal edema. Clin Nephrol. 1974; 2:157-160.
46. Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol. 1977;17:243-251.
47. Schonees R, Mostert JW, Moore RH. Evaluation of metolazone, new diuretic in chronic renal disease. N Y State J Med. 1971;71:566-569.
48. Reubi FC, Cottier PT. Effect of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation. 1961;23:200-210.
49. Woolam GL, Tarazi RC, Bravo EL, et al. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med. 1982;72:929-938.
50. Lowenthal DT, Shear L. Use of a new diuretic agent (metolazone) in patients with edema and ascites. Arch Intern Med. 1973;132:38-41.
51. Hillenbrand P, Sherlock S. Use of metolazone in the treatment of ascites due to liver disease. BMJ. 1971;4:266-270.
52. Lang GR, Westenfelder C, Nascimento L. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome. Clin Pharmacol Ther. 1977;21:234-243.
53. Bennett Wm, Porter GA. Efficacy and safety of metolazone in renal failure and the nephrotic syndrome. J Clin Pharmacol. 1973;13:357-364.
54. Chemtob S, Kaplan BS, Sherbotie JR, et al. Pharmacology of diuretics in the newborn. Pediatr Clin North Am. 1989;36: 1231-1250.
55. Mirochnick MH, Micelli JJ, Kramer PA, et al. Furosemide pharmacokinetics in very low birth weight infants. J Pediatr. 1988;112:653-657.
56. Vert P, Broquaire M, Legagneur M, et al. Pharmacokinetics of furosemide in neonates. Eur J Clin Pharmacol. 1982;22: 39-45.
57. Chemtob S, Papageorgiou A, du Sonich P, et al. Cumulative increase in serum furosemide concentration following repeated doses in the newborn. Am J Perinatol. 1987;4:203-205.
58. Aranda JV, Turmen T, Sasyniuk BI, Pharmacokinetics of diuretics and methylxanthines in the neonate. Eur J Clin Pharmacol. 1980;18:55-63.
59. Allen LV Jr, Erickson MA. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids. Am J Health Syst Pharm. 1996;53:2073-2078.
60. Whang R, Whang DD, Ryan MP. Refractory potassium depletion: a consequence of magnesium deficiency. Arch Intern Med. 1992;152:40-45.